Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal doxorubicin chemotherapy and tissue Doppler imaging evaluation in first-line breast cancer
2005-003092-20Phase 3Completed
- Sponsor
- Policlinico Gemelli
- Start
- Apr 2007
- Modality
- Small Molecules, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of pegylated liposomal doxorubicin in breast cancer, sponsored by Policlinico Gemelli. Started Apr 2007; status: completed.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2005-003092-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003092-20.